You are currently on the new version of our website. Access the old version .

Most Recent

  • Article
  • Open Access
145 Views
9 Pages

Patient-Derived Microtumors: How Can We Continue to Personalize Treatment for Ovarian Cancer Patients?

  • Emily O'Brien,
  • Dhruva Dave,
  • Abbie Kleckley,
  • Fibiana Oladipo,
  • Christopher M. Mayer,
  • Rebecca Henderson,
  • Blanca Vasquez,
  • Elizabeth Lucas,
  • Jeffrey A. Thomas and
  • Rebecca C. Arend
  • + 5 authors

12 January 2026

Background/Objectives: This pilot study investigates the feasibility of using patient-derived microtumors (PDMs) to assess chemotherapy response in epithelial ovarian cancer. Methods: Fresh tissue from 10 patients was used to develop PDMs, which were...

  • Article
  • Open Access
224 Views
30 Pages

Molecular Modeling Reveals Selective AChE Inhibitor Against Bemisia tabaci Pest

  • Fernanda F. de Souza,
  • Juliana F. Vilachã,
  • Othon S. Campos and
  • Heberth de Paula

31 December 2025

Acetylcholinesterase (AChE) is an important molecular target in the development of insecticides, but due to also being found in the human body, it is necessary to characterize the inhibitory profile of compounds to achieve selectivity. In this study,...

  • Review
  • Open Access
752 Views
52 Pages

15 December 2025

Breast cancer is a substantial and growing public health issue in India, with epidemiological data demonstrating distinct and often severe disease characteristics in contrast to Western countries. Contrary to the global trend, Indian women frequently...

  • Case Report
  • Open Access
324 Views
6 Pages

Fatal Early Toxicity After Allogeneic Stem Cell Transplantation in Heavily Pretreated Follicular Lymphoma: Clinical Decision-Making Between Bispecific Antibodies and CAR T-Cell Therapy

  • Martina Canichella,
  • Raffaella Cerretti,
  • Monika Malgorzata Trawinska,
  • Mariagiovanna Cefalo,
  • Luca Cupelli,
  • Carla Mazzone,
  • Alessandra Checcoli,
  • Alice Di Rocco,
  • Paolo de Fabritiis and
  • Elisabetta Abruzzese

10 December 2025

For patients with relapsed/refractory (R/R) follicular lymphoma (FL) after ≥2 prior lines of therapy, T-cell-redirecting therapies—including the bispecific CD3xCD20 antibody (BsAbs) mosunetuzumab (mosu) and chimeric antigen receptor T-cell (...

  • Article
  • Open Access
496 Views
16 Pages

6 December 2025

In Norway, organized cervical cancer screening was cytology-based until 2023, and women screened in 2013–2015 were largely unvaccinated. We conducted a retrospective, population-based cohort study to assess whether co-testing with a 3-type HPV...

  • Article
  • Open Access
699 Views
24 Pages

27 November 2025

Aberrant activation of fibroblast growth factor receptor 1 (FGFR1) drives tumor progression in multiple cancer types, yet existing FGFR1 inhibitors suffer from suboptimal target selectivity and dose-limiting toxicities. This study describes an integr...

  • Review
  • Open Access
1,129 Views
20 Pages

Galectin-3: A Multitasking Protein Linking Cardiovascular Diseases, Immune Disorders and Beyond

  • Mariarosaria Morello,
  • Gisella Titolo,
  • Saverio D’Elia,
  • Silvia Caiazza,
  • Ettore Luisi,
  • Achille Solimene,
  • Chiara Serpico,
  • Andrea Morello,
  • Francesco Natale and
  • Giovanni Cimmino
  • + 2 authors

15 November 2025

In recent decades, the novel role of Galectin-3 (Gal-3) in both physiological and pathological conditions has emerged. Gal-3 is a key protein involved in immunity, inflammation, cell adhesion, proliferation, differentiation, and apoptosis. Its physio...

  • Article
  • Open Access
878 Views
27 Pages

30 October 2025

Although traditionally contraindicated, the coadministration of tamoxifen and estradiol may hold clinical relevance in specific contexts, particularly in breast cancer survivors with premature menopause and a high risk of osteoporosis, thereby justif...

  • Review
  • Open Access
4 Citations
1,438 Views
28 Pages

17 October 2025

Extracellular Vesicle-associated microRNAs (EV-miRNAs) are emerging as pivotal regulators of corneal health and disease, holding exceptional promise for transforming both diagnostics and therapeutics. These vesicles carry distinct miRNA signatures in...

  • Review
  • Open Access
1 Citations
1,705 Views
35 Pages

14 October 2025

Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults. This review explains the connections between the genesis and progression of GBM and particular cellular tumorigenic mechanisms, such as angiogenesis, invasion, migr...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Targets - ISSN 2813-3137